Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ATI Physical Therapy, Inc. stock logo
ATIP
ATI Physical Therapy
$1.03
$0.94
$0.41
$6.59
$4.54M-0.1539,079 shsN/A
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
$5.29
-2.0%
$6.63
$3.80
$10.50
$23.44M-0.916,223 shs544 shs
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
$0.33
-14.8%
$0.32
$0.25
$1.19
$17.03M1.19171,850 shs4.12 million shs
Marpai, Inc. stock logo
MRAI
Marpai
$1.28
-6.6%
$1.33
$0.40
$1.68
$21.17M4.6817,380 shs16,687 shs
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ATI Physical Therapy, Inc. stock logo
ATIP
ATI Physical Therapy
0.00%0.00%+3.00%+14.44%-82.48%
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
-2.96%+1.09%-3.86%+32.92%-34.17%
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
0.00%0.00%0.00%+0.62%-72.22%
Marpai, Inc. stock logo
MRAI
Marpai
-0.72%+0.74%+5.38%+30.48%+101.47%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
ATI Physical Therapy, Inc. stock logo
ATIP
ATI Physical Therapy
N/AN/AN/AN/AN/AN/AN/AN/A
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
0.7955 of 5 stars
0.05.00.00.00.01.70.6
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
N/AN/AN/AN/AN/AN/AN/AN/A
Marpai, Inc. stock logo
MRAI
Marpai
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ATI Physical Therapy, Inc. stock logo
ATIP
ATI Physical Therapy
0.00
N/AN/AN/A
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
0.00
N/AN/AN/A
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
0.00
N/AN/AN/A
Marpai, Inc. stock logo
MRAI
Marpai
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ATI Physical Therapy, Inc. stock logo
ATIP
ATI Physical Therapy
$741.86M0.01$5.42 per share0.19($23.96) per share-0.04
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
$52.60M0.44N/AN/A$51.05 per share0.10
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
$29.09M0.59N/AN/A$1.09 per share0.30
Marpai, Inc. stock logo
MRAI
Marpai
$34.87M0.61N/AN/A($1.72) per share-0.74
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ATI Physical Therapy, Inc. stock logo
ATIP
ATI Physical Therapy
-$69.79M-$19.42N/AN/A-7.79%N/A-3.87%7/23/2025 (Estimated)
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
-$42.23MN/A0.00N/AN/AN/AN/AN/A
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
-$26.08MN/A0.00N/A-75.34%-7.96%-5.49%N/A
Marpai, Inc. stock logo
MRAI
Marpai
-$28.75M-$1.82N/AN/A-85.70%N/A-100.23%8/5/2025 (Estimated)
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
ATI Physical Therapy, Inc. stock logo
ATIP
ATI Physical Therapy
N/AN/AN/AN/AN/A
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
N/AN/AN/AN/AN/A
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
$0.40123.08%N/AN/AN/A
Marpai, Inc. stock logo
MRAI
Marpai
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
ATI Physical Therapy, Inc. stock logo
ATIP
ATI Physical Therapy
N/A
1.12
1.12
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
1.67
0.46
0.45
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
N/A
2.55
2.28
Marpai, Inc. stock logo
MRAI
Marpai
N/A
0.82
0.82

Institutional Ownership

CompanyInstitutional Ownership
ATI Physical Therapy, Inc. stock logo
ATIP
ATI Physical Therapy
72.60%
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
N/A
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
36.90%
Marpai, Inc. stock logo
MRAI
Marpai
49.75%

Insider Ownership

CompanyInsider Ownership
ATI Physical Therapy, Inc. stock logo
ATIP
ATI Physical Therapy
3.30%
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
46.50%
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
11.40%
Marpai, Inc. stock logo
MRAI
Marpai
46.10%
CompanyEmployeesShares OutstandingFree FloatOptionable
ATI Physical Therapy, Inc. stock logo
ATIP
ATI Physical Therapy
5,6004.41 million4.27 millionNo Data
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
9704.34 million2.32 millionNot Optionable
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
52052.40 million46.29 millionOptionable
Marpai, Inc. stock logo
MRAI
Marpai
15016.54 million5.61 millionNo Data

Recent News About These Companies

Marpai, Inc. Reports Q1 2025 Financial Results
Marpai, Inc. (MRAI) Q1 2025 Earnings Call Transcript
Marpai appoints new COO to accelerate growth
Market Access RICI Agriculture UCITS (MRAI)
Marpai, Inc. (MRAI) Q4 2024 Earnings Call Transcript
MARPAI ANNOUNCES PRICING OF $700,000 PRIVATE PLACEMENT
MARPAI ANNOUNCES GENERAL UPDATES FOR Q4
Marpai, Inc. Reports Q3 2024 Financial Results

New MarketBeat Followers Over Time

Media Sentiment Over Time

ATI Physical Therapy stock logo

ATI Physical Therapy NYSE:ATIP

$1.03 0.00 (0.00%)
As of 07/17/2025

ATI Physical Therapy, Inc. operates as an outpatient physical therapy provider that specializes in outpatient rehabilitation and adjacent healthcare services in the United States. It offers a range of services to its patients, including physical therapy to treat spine, shoulder, knee, and neck injuries or pain; work injury rehabilitation services, work conditioning and work hardening; and hand therapy, aquatic therapy, functional capacity evaluation, sports medicine, and wellness programs. It also provides ATI worksite solutions comprising injury prevention programs, work-related injury assessment services, wellness offerings, and consultations for employers; proprietary electronic medical records (EMR) integration, caseload management, and continuing education in therapy treatments; and sports medicine, including on-site sports physical therapy, clinical evaluation and diagnosis, immediate and emergency care, nutrition programs, and concussion management services. The company offers outpatient physical therapy services under the ATI brand name. ATI Physical Therapy, Inc. was founded in 1996 and is based in Bolingbrook, Illinois.

Concord Medical Services stock logo

Concord Medical Services NYSE:CCM

$5.29 -0.11 (-2.02%)
Closing price 03:58 PM Eastern
Extended Trading
$5.24 -0.05 (-0.87%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital. The company's services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services. Its other treatments and diagnostic services comprise positron emission tomography-computed tomography and magnetic resonance imaging scanners. In addition, the company provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, it offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, the company operates specialty cancer hospitals, which offers radiation, imaging, test laboratory, inpatient, and nursing services. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, the People's Republic of China.

Enzo Biochem stock logo

Enzo Biochem NYSE:ENZ

Enzo Biochem, Inc. develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis. It also provides AMPIVIEW in situ hybridization probes for enhanced detection of low expressed targets useful in the growing spatial biology space; reagents and assays for cell and gene therapy research and development; POLYVIEW PLUS Enhanced Immunohistochemistry platform, offers solutions within the area of anatomical pathology through optimized assays; Enhanced Immunoassays, pushing sensitivity to expand immunoassay applications for basic research, bioprocess, and diagnostics; AMPIPROBE, a nucleic acid amplification platform; and Axxora.com, a proven distribution platform for original manufacturers of innovative research reagents. The company's proprietary products and technologies in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry. It markets its products and services through its direct sales force and a network of distributors. The company was incorporated in 1976 and is headquartered in Farmingdale, New York.

Marpai stock logo

Marpai NASDAQ:MRAI

$1.28 -0.09 (-6.57%)
As of 03:57 PM Eastern

Marpai, Inc., a technology-driven healthcare payer, focuses on providing services to the self-insured employer market in the United States and Israel. The company offers ancillary services, such as care management, case management, actuarial services, bill review and cost containment services. Marpai, Inc. was incorporated in 2021 and is based in Tampa, Florida.